1. Home
  2. TWI vs ANNX Comparison

TWI vs ANNX Comparison

Compare TWI & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Titan International Inc. (DE)

TWI

Titan International Inc. (DE)

HOLD

Current Price

$9.92

Market Cap

691.3M

Sector

Industrials

ML Signal

HOLD

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$5.38

Market Cap

730.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWI
ANNX
Founded
1890
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
691.3M
730.4M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
TWI
ANNX
Price
$9.92
$5.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$11.50
$16.50
AVG Volume (30 Days)
551.9K
1.8M
Earning Date
06-01-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
42.94
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.93
$1.29
52 Week High
$11.70
$7.18

Technical Indicators

Market Signals
Indicator
TWI
ANNX
Relative Strength Index (RSI) 45.89 49.35
Support Level $8.24 $4.65
Resistance Level $10.03 $5.48
Average True Range (ATR) 0.50 0.31
MACD -0.16 -0.04
Stochastic Oscillator 19.47 57.67

Price Performance

Historical Comparison
TWI
ANNX

About TWI Titan International Inc. (DE)

Titan International Inc is a manufacturer of wheels, tires, wheel and tire assemblies, and undercarriage systems and components for off-highway vehicles. The company operates through three segments namely Agricultural, Earthmoving/Construction, and Consumer. Geographically, business of the group can be seen in the United States, Europe / CIS, Latin America and Other international. Titan derives majority of the revenue from Agricultural segment which manufacture various agricultural equipment, including tractors, combines, plows, planters and irrigation equipment, and are sold directly to original equipment manufacturers and to the aftermarket through independent distributors, equipment dealers and Titan's own distribution centers.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: